DUBLIN, June 28, 2021 /PRNewswire/ -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced key clinical data from the virtual 81st annual American Diabetes Association ...
Medtronic MDT continues to grab headlines with respect to its Diabetes management business update. Following two back-to-back European approvals last month for its InPen smart insulin pen as well as ...
Data collected from users of Medtronic’s InPen smart insulin pen between January 2018 and October 2020 showed that using the device slightly improved the time they spent in their target blood sugar ...
Medtronic's launch of a new version of its smart insulin pen with integrated continuous glucose monitoring (CGM) is the first such "connected" device for use by people with diabetes who use multiple ...
GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE American: SENS) a medical technology company focused on the development and commercialization of the first and only long-term, ...
Given the direct reference to Medtronic's InPen, its new campaign goes beyond just awareness and into a fully branded promotion of the tech. (Medtronic) Medtronic is turning to a celebrity endorsement ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results